← Back to Search

Local Anesthetic

Eyelid Lesion Removal for Local Anesthesia

Phase 4
Waitlist Available
Led By Robert Kersten, MD
Research Sponsored by University of California, San Francisco
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 10 minutes
Awards & highlights

Study Summary

This trial will compare the pain levels of those who receive traditional local anesthesia to those who receive bacteriostatic saline for minor eyelid procedures.

Eligible Conditions
  • Local Anesthesia
  • Stye
  • Ptosis
  • Eyelid Papilloma
  • Eye Care
  • Eyelid Tumors
  • Eyelid Abscess

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~10 minutes
This trial's timeline: 3 weeks for screening, Varies for treatment, and 10 minutes for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Pain of procedure
Pain
Secondary outcome measures
Additional Anesthesia
Bleeding level

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Bacteriostatic Saline as Local AnesthesiaExperimental Treatment2 Interventions
Patients receiving bacteriostatic saline as local anesthesia for in-office minor eyelid procedures at University of California, San Francisco Medical Center, Oculoplastics department
Group II: Lidocaine with Epinephrine as Local AnesthesiaActive Control2 Interventions
Patients receiving lidocaine with epinephrine as local anesthesia for in-office minor eyelid procedures at University of California, San Francisco Medical Center, Oculoplastics department
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
0.9% Bacteriostatic Local Anesthetic Injection
2022
Completed Phase 4
~100
Eyelid Lesion Removal
2022
Completed Phase 4
~100

Find a Location

Who is running the clinical trial?

University of California, San FranciscoLead Sponsor
2,498 Previous Clinical Trials
11,936,253 Total Patients Enrolled
Robert Kersten, MDPrincipal InvestigatorUniversity of California, San Francisco
1 Previous Clinical Trials
401 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who can sign up for this particular clinical trial?

"Eligible participants for this study must have seen an ophthalmologist and be between 18-110 years old. A total of 150 people will be accepted into the trial."

Answered by AI

What risks are associated with Eyelid Lesion Removal surgery?

"Eyelid Lesion Removal is a Phase 4 trial, so it has already been approved and scored as a 3 on the Power team's safety scale."

Answered by AI

Will this program be testing its treatments on elderly patients?

"The requirements to take part in this trial state that potential participants must be between 18-110 years old. There are 23 similar trials for people under 18 and 81 for those 65 and older."

Answered by AI

Are patient volunteers currently being accepted for this research project?

"According to the most recent information available on clinicaltrials.gov, this particular trial is no longer seeking patients for participation. The study was originally posted on May 1st, 2022 and updated for the last time on March 23rd, 2022. It's worth mentioning that there are 106 other trials currently looking for eligible participants."

Answered by AI
~33 spots leftby Apr 2025